Frontiers in Immunology
免疫学前沿
ISSN: 1664-3224
自引率: 11.2%
发文量: 2924
被引量: 45626
影响因子: 8.777
通过率: 暂无数据
出版周期: 不定期刊
审稿周期: 4.53
审稿费用: 0
版面费用: 暂无数据
年文章数: 2924
国人发稿量: 188

投稿须知/期刊简介:

Frontiers in Immunology&nbsp;is a peer-reviewed Open Access Journal, and the official Journal of theInternational Union of Immunological Societies&nbsp;(IUIS). It provides a novel way to disseminate the latest findings in basic and translational research in Immunology and to facilitate communication, both among scientists as well as the community at large.<br>Frontiers in Immunology&nbsp;aims to publish the most outstanding research findings encompassing the entire field of Immunology. In addition to papers that investigate basic mechanisms of immune system development and function, a particular emphasis is given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis. Furthermore, availability of a growing number of biological drugs, coupled with fine characterization of the molecular mechanisms of disease, has now made precision medicine a desirable approach for many immunological disorders.&nbsp;Frontiers in Immunology&nbsp;intends to portray how advances of scientific knowledge and technology may translate into novel approaches to diagnosis and treatment of immune disorders, both in animal and cellular models and in humans.<br>All manuscripts submitted to Frontiers in Immunology that report on studies conducted in human subjects must conform with current regulation and the Declaration of Helsinki, and must receive approval from the Institutional Review Board and patient informed consent. Animal welfare and Ethics Committee approval is required for studies involving animals.<br><br>Frontiers in Immunology&nbsp;is organized into Specialty Sections that cover different areas of research in Immunology.&nbsp; Authors should refer to the author guidelines for details on article types and the submission process. &nbsp;<br>

期刊描述简介:

Frontiers in Immunology is a peer-reviewed Open Access Journal, and the official Journal of theInternational Union of Immunological Societies (IUIS). It provides a novel way to disseminate the latest findings in basic and translational research in Immunology and to facilitate communication, both among scientists as well as the community at large. Frontiers in Immunology aims to publish the most outstanding research findings encompassing the entire field of Immunology. In addition to papers that investigate basic mechanisms of immune system development and function, a particular emphasis is given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis. Furthermore, availability of a growing number of biological drugs, coupled with fine characterization of the molecular mechanisms of disease, has now made precision medicine a desirable approach for many immunological disorders. Frontiers in Immunology intends to portray how advances of scientific knowledge and technology may translate into novel approaches to diagnosis and treatment of immune disorders, both in animal and cellular models and in humans. All manuscripts submitted to Frontiers in Immunology that report on studies conducted in human subjects must conform with current regulation and the Declaration of Helsinki, and must receive approval from the Institutional Review Board and patient informed consent. Animal welfare and Ethics Committee approval is required for studies involving animals. Frontiers in Immunology is organized into Specialty Sections that cover different areas of research in Immunology. Authors should refer to the author guidelines for details on article types and the submission process.

最新论文
统计分析
是否有问题?您可以直接对期刊官方提问 提问

最近浏览

关于我们

zlive学术集成海量学术资源,融合人工智能、深度学习、大数据分析等技术,为科研工作者提供全面快捷的学术服务。在这里我们不忘初心,砥砺前行。

友情链接

联系我们

合作与服务

©2024 zlive学术声明使用前必读